MoRD charts roadmap for Women-Led Rural Marketing Ecosystems (See 'Corp Brief') Pharmacopoeia Commission organizes 5-Day Capacity Building Training (See 'Corp Brief') Saurabh Vijay assumes charge as CEO of Unique Identification Authority of India (See 'Corp Brief') Companies Act - Appellant company directed to change its name where it significantly resembles the name of a pre-existing company and may cause confusion: HC (See 'Legal Desk') Minister reviews technology-led underground mining, integrated smelting operations (See 'Corp Brief') Scientific Steering Committee Meeting on National One Health Mission Held in New Delhi (See 'Corp Brief') Govt launches campaign to reduce edible oil consumption (See 'Corp Brief') PMLA - Provisional attachment unsustainable when Initiating Officer fails to establish source of consideration & beneficial ownership as per Section 2(9)(A): SAFEMA (See 'Legal Desk') HM inaugurates 'Million Minds Tech Park' and 'GREMI City Campus' in Ahmedabad (See 'Corp Brief') Amit Shah inaugurates State-of-the-Art Milk Processing Plant of Madhur Dairy (See 'Corp Brief') Experts Discuss Yoga for Youth and Mental Wellness in Digital Era (See 'Corp Brief') Misc - RBI circular dated June 07, 2019 on 'Prudential Framework for Resolution of Stressed Assets' was policy decision taken by expert body in larger public interest: HC (See 'Legal Desk') GeM continues to support Digital Public Procurement System (See 'Corp Brief') Ministry of Education reviews strategy for mainstreaming Out-of-School children (See 'Corp Brief') Misc - NBFC cannot reposses financed vehicle through coercive means, without adherence to due process of law and in violation of RBI recovery guidelines: HC (See 'Legal Desk') Govt extends timeline for Global Tender for REPM scheme (See 'Corp Brief') Indian Pharmacopoeia Commission organizes Scientific Conclave (See 'Corp Brief') A&C - Later attempt by insurer to artificially split same claim into separate components of admitted and denied liability does not render unpaid component non-arbitrable: HC (See 'Legal Desk') Scindia reviews Key Development Projects during Sikkim Visit (See 'Corp Brief') Union Minister of State for Coal & Mines reviews CMPDIL (See 'Corp Brief') IBC - If transaction was builder-linked contractual arrangement rather than pure financial debt default, Section 7 IBC proceedings cannot be used in parallel with DRT recovery proceedings: SC (See 'Legal Desk') Commerce Minister chairs meet on promoting fisheries exports (See 'Corp Brief') Govt reviews progress of micro Food Processing Enterprises in Leh (See 'Corp Brief') FERA - Foreign judgment is unenforceable in India as it fell within exceptions u/s 13 CPC: SC (See 'Legal Desk') Railways carries 170% more Cement in last 4 Months (See 'Corp Brief') A&C - Once seat of arbitration is expressly designated by agreement of parties, that seat becomes juridical home of arbitration and operates akin to exclusive jurisdiction clause: SC (See 'Legal Desk') Self-reliance and jointness must for strategic autonomy & future-ready force: RM (See 'Corp Brief') Company Law - For purpose of maintainability of petitions u/s 397 & 398, expression ‘member' is not to be confined only to formal entry in register of members u/s 41(2): SC (See 'Legal Desk') NCB launches 6-Month Online Certification Program on Advanced Concrete Technology (See 'Corp Brief') IBC - While subsidiary companies are separate legal entities, corporate veil may be lifted if associated companies are inextricably connected so as to form one concern: SC (See 'Legal Desk') Supreme Court lays down scenarios for lifting of Doctrine of Corporate Veil (See 'CORP EINSICHTf')

Print

Pharmacopoeia Commission organizes 5-Day Capacity Building Training

Published: May 19, 2026

By TIOLCorplaws News Service

NEW DELHI, MAY 19, 2026: THE Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush, is organizing a five-day Capacity Building Training Program from 18th to 22nd May 2026. The programme is being conducted for drug regulators, enforcement authorities, quality control personnel, technical experts, faculty members, government analysts, researchers and scientists working in the field of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) medicines.

The programme aims to strengthen the knowledge, technical skills and professional capabilities of stakeholders associated with the regulatory, academic, quality control and manufacturing sectors of ASU&H drug development.

The inaugural session of the programme was graced by Jaspal Kaur Pradyot, Chief Controller of Accounts, Ministry of Health & Family Welfare, as the Chief Guest. In her address, she appreciated PCIM&H for its significant contribution towards the development of quality standards for ASU&H drugs through the adoption of modern instruments and advanced scientific techniques. She also highlighted the rich heritage of AYUSH systems of medicine and their growing global acceptance and popularity.

Dr. Abdul Qayum, Director (Technical) & Deputy CEO, National Medicinal Plants Board, Ministry of Ayush, attended the programme as the Guest of Honour. He emphasized the international recognition of the pharmacopoeias and formularies developed by PCIM&H and noted the increasing global demand and acceptance of ASU&H systems of medicine.

Welcoming the dignitaries and participants, Dr. Raman Mohan Singh, Director, PCIM&H, provided an overview of the organization and highlighted its key activities in the standardization and quality control of ASU&H medicines.

During the five-day programme, participants will receive expert-led lectures on various important aspects including NABL Accreditation and Quality Management Systems (QMS), Good Manufacturing Practices (GMP), pharmacognostic, physico-chemical, phytochemical, microbiological and pharmacological evaluation of ASU&H drugs, standardization and quality control of herbal drugs, regulatory and pharmacopoeial aspects of ASU&H medicines, and shelf-life studies of ASU&H drugs.

Participants will also undergo hands-on laboratory training at PCIM&H and participate in field visits to leading ASU&H drug manufacturing units, including Dr. Willmar Schwabe India Pvt. Ltd., Noida, and Hamdard Laboratories India, Ghaziabad. These visits are aimed at providing practical exposure to modern technologies, manufacturing practices and quality assurance systems adopted in the industry.

The programme has attracted 28 participants from across the country representing a diverse range of institutions and organizations, including State Drug Controllers, Drug Inspectors, Professors, Faculty Members, Research Officers, AYUSH-accredited Drug Testing Laboratories, National Institutes and Research Centres such as the National Institute of Siddha, Chennai; Siddha Central Research Institute, Chennai; Central Drugs Laboratory, Kolkata; Regional Ayurveda Research Institute (CCRAS), Jammu and Jhansi; and ASU&H drug manufacturing units.

This Capacity Building Training Program is a significant initiative by PCIM&H aimed at promoting professional excellence and strengthening quality standards within the ASU&H sector. By equipping stakeholders with updated technical knowledge and practical expertise, the programme seeks to further reinforce India's leadership in the global regulation, standardization and development of traditional systems of medicine.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.